Antiplatelet regimens following carotid artery revascularization

Megan Lee1, Zain V Ahmed2, Jiaming Huang2

  • 1Yale School of Medicine, Yale New Haven Health System, CT.

Insights

Guidelines recommend dual antiplatelet therapy (DAPT) after carotid artery stenting (CAS) and single antiplatelet therapy (SAPT) after carotid endarterectomy (CEA). Real-world adherence is high for CAS but variable for CEA.

Area of Science:

  • Cardiovascular Medicine
  • Neurosurgery
  • Vascular Surgery

Background:

  • Dual antiplatelet therapy (DAPT) is standard post-carotid artery stenting (CAS).
  • Single antiplatelet therapy (SAPT) is standard post-carotid endarterectomy (CEA).
  • Real-world adherence to these guideline-based antiplatelet regimens remains unclear.

Discussion:

  • Analysis of 12,257 patients from the Vascular Quality Initiative New England data.
  • 82% of patients received DAPT after CAS, aligning with guidelines.
  • Only 66% of patients received SAPT after CEA, indicating lower adherence.

Key Insights:

  • High adherence to DAPT post-CAS suggests effective guideline implementation.
  • Lower and more variable adherence to SAPT post-CEA highlights potential areas for quality improvement.
  • Discrepancies in antiplatelet therapy use may impact patient outcomes.

Outlook:

  • Further research needed to understand reasons for SAPT variability after CEA.
  • Interventions may be necessary to improve adherence to SAPT guidelines for CEA.
  • Optimizing antiplatelet strategies is crucial for preventing cerebrovascular events.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
625
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
27
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
28
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
20
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31